A Placebo-Controlled, Double-Blind Randomized (Phase IIB) Trial of Oral Administration with HPV16 E7-Expressing <i>Lactobacillus</i>, GLBL101c, for the Treatment of Cervical Intraepithelial Neoplasia Grade 2 (CIN2).

Oral administration of GLBL101c trended to elicit an increase in E7-specific IFNγ-producing cells in CxLs and PBMCs at weeks 9 and 16 in this patient, although the difference between E7 stimulation and no stimulation had marginal significance ( Figure 2 ).

also in 5,069 other papers